Matt Might, Ph.D., a strategic leader in the White House Precision Medicine Initiative, has been named the inaugural director of the Hugh Kaul Personalized Medicine Institute at UAB.
Some people inherit a condition that elevates their cholesterol to an excessive degree, and no amount of diet or exercise can bring the numbers down. UAB researchers are developing and testing a new peptide that may lead to better treatment options.
UAB’s annual Reynolds-Finley Lecture will feature discussion of the collaboration between UAB and HudsonAlpha in precision medicine.
Exercise medicine gets a boost with the opening of the 7,000-square-foot UAB Exercise Clinical Trial Facility.
UAB will bring proton therapy, one of the most technically advanced forms of cancer-killing radiation, to Alabama with the new Proton Therapy Center.
A 90-ton machine called a cyclotron will accelerate protons to very high speeds to impact human tumors.
A UAB study shows specialized treatment sites contribute to better survival rates for those with acute leukemia. 
According to the National Heart, Lung and Blood Institute, 23 percent of women will die within one year after having a heart attack , and nearly 46 percent of women become disabled with heart failure.
Page 28 of 168